ارزیابی روش‌های تنظیم‌گری تبلیغات دارویی

 

 

A (Articles

5. Azevedo, Jorge & colleagues-GlobalHealthPR (2013),” The Global Guide to Pharma Marketing Codes,GlobalHealthPR(Aurora),Vol.3, pp.1-173.
6. Bennadi, Darshana (2014),” Self-medication: A current challenge”,Journal of Basic and Clinical Pharmacy,Vol.5, Issue.1.pp.19-23.
7. Borhani, Mohsen & Abuzari, Mehrnoosh (2017), " The Right to Medications along with Supporting Drug Innovations", Legal Journal of Justice, No. 99, pp. 11-30 (In Persian).
8. Chepesiuk,Ray,(2005)“Standards for pharmaceutical advertising in Canada”, CMAJ&JAMC,Vol.173, No.3,publishonline: https://www.ncbi.nlm.nih.gov/
9. Donohue, Julie (2006),” A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection”, the Milbank Quarterly,Vol.84, No.4, pp.659-699
10. Erfanmanesh, Mohammadhosein; Zahedi, Mahdi; Abbasi, Mahmood (2016), “Examination of Status and Challenges of Pharmaceutical Trademarks Registration in European”, Medical Law Journal, Vol.10, No. 36,, pp.127-150 (In Persian).
11. Ghahremani Afshar, Newsha & Alizadeh Gholilo, Saeed (2015), "Investigation of Organized Crime with Emphasis on Drug Trafficking and Preventive Strategies", Quarterly Journal of Social Health & Addiction, Vol. 2, No.7, pp. 123-150 (In Persian).
12. Imamian, Seyed Mohammad Sadegh; Zolfaghari, Amira Ahmad; Mohammadzadeh, Ehsan & Zamanian, Morteza (2018), "National system of regulation: 1. The concept of regulation and its relationship with the system of government ", Office of Economic Studies of the Public Sector, Deputy of Economic Research, Parliamentary Research Center, Subject Code 230, Serial Number 15940 (In Persian).
13. João Luis Vianna, Lívia Figueiredo and Anderson Ribeiro (2018)” Distribution and marketing of drugs in Brazil: overview”, ACC(Association of corporate counsel), pp.1-8, , publish online :www.global.practicallaw.com
14. Kasraie M; Moradkhani H; Rezaei M. (2012), “Foucault: Governmentality, Political Subject and Political Action”, MJSS journal, Vol. 3 , No.2, pp.1-34 (In Persian).
15. Khandouzi, seyed Ehsan (2010), " Requirements of Regulatory State in the Iranian Economy", majlis & rahbord journal, No. 64, pp. 41-80 (In Persian).
16. Lee Ventola.C, (2011),”Direct-to-Consumer Pharmaceutical Advertising/Therapeutic or Toxic?” P&TJournal(pharmacy and therapeutics),Vol.36, No.10, pp.669-684.
17. Leonardo Alves, Teresa & Joel Lexchin, Barbara Mintzes (2018), “Medicines Information and the Regulation of the Promotion of Pharmaceuticals”, Springer: Science and Engineering Ethics,Vol.25, No.4, pp.1167-1192.
18. Matheson, Alastair (2017), “Marketing trials, marketing tricks-how to spot them and how to stop them”,Journal trials,Vol.18, No.105, publish online:https://www.ncbi.nlm.nih.gov/
19. Praneeth. P (2016), “Regulatory Affairs and its Role in Pharmaceutical Industry”, International Journal of Pharmacy and Biomedical Engineering, Vol.3, Issue1. publish online: www.internationaljournalssrg.org
20. Sadeghi, Mohsen (2009), "The protection of pharmaceutical inventions and human rights challenges", Quarterly Journal of Private Law Studies, University of Tehran, Vol. 39, No. 3, pp. 193-215 (In Persian).
21. Sedighi, Davood (2016), "Introduction to the indicators of postmodern government", Office of Basic Government Studies, Research Center of the Islamic Consultative Assembly, Subject Code 330, Serial Number 14869 (In Persian).
22. Valizadeh, Hossein (2019), "Regulatory Analysis, Privatization in Iran", Qanuniyar Quarterly, Vol. 3, No. 11, pp. 255-298 (In Persian).
23. Yavari, Asadollah (2014), " An introduction to concept of legal regulation", Journal of Comparative Law Studies, University of Tehran, Vol. 5 – No. 2, pp. 629-647 (In Persian).

 

 

1. C) Documents
2. Newsland medicines and medical devices safety authority, Guideline on the Regulation of Therapeutic Products in New Zealand, Part7: Advertising of therapeutic products, December 2019, pp.1-15.
3. Un,convention on Psychotropic substances,1971.
4. WTO, Declaration on the trips agreement and public health, 14 November 2001, WT/MIN(01)/DEC/2, NO.7.
5. WHO, Approved by Medicine Advertisements Board(2015), Advertising of Medicines and Medicinal Products to General Public,Last date 25 January 2020,available in:http://apps.who.int/medicinedocs/en/m/abstract/Js23092en/

 

1. D) Reports
2. MHRA(Medicines and Healthcare products Regulatory Agency),(2019)” The Blue Guide-Advertising and Promotion of Medicines in the UK”, Advertising Standards and Outreach Unit,www.mhra.gov.uk
3. PricewaterhouseCoopers-PWC (2020),“Pharma 2020:Marketing the future/Which path will you take?” pwc.com/pharma, pp.1-28.
4. Ratanawijitrasin, Sauwakon, Wondemagegnehu, Eshetu (2002), “Effective drug regulation(A multicountry study), World Health Organization Pub(report):https://apps.who.int/medicinedocs/pdf/s2300e/s2300e.pdf

 

1. E) Website
2. Chameleon pharma consulting: pharma regulatory, lastdate 26January 2020,available in: https://www.chameleon-pharma.com/services/regulatory-registration/
3. FDA: Prescription Drug Advertising: Questions and Answers,2015,Last date 30 November 2019 , available in:

https://www.fda.gov/drugs/prescription-drug-advertising/prescription-drug-advertising-questions-and-answers

33. ICLG website, USA: Pharmaceutical Advertising 2019,available in: https://iclg.com/practice-areas/pharmaceutical-advertising-laws-and-regulations/usa

34.Preker, Alexander S.,10 July 2015, Welcome to the Health Industry, last date 8June 2020, available in: http://www.healthindustry.com/test-art/homepage/industry-profiles/welcome-to-health-industry

35. Chambers and partners, (Last Updated June 11,2019) Pharmaceutical Advertising(china), last date 28 January 2020, available in:

https://practiceguides.chambers.com/practice-guides/pharmaceutical-advertising-2019/china